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Stem cell therapy of the intervertebral disc (IVD) is one of the most warranted but also highly 
disputed procedures to be applied for treatment of degenerated discs that in many cases cause 
high low back pain. From previous studies it is known that for instance notochordal cells, a 
relatively large cell type containing a high number of vesicles, are highly regenerative [1] and 
may stimulate other differentiated cells, such as nucleus pulposus cells (NPC) to produce 
more matrix.  
Lately, a particular tissue-specific progenitor cell population has been identified in the center 
of the intervertebral disc (IVD), so-called nucleus pulposus progenitor cells (NPPC) [2]. The 
current hope is that these NPPC could play a particular role for IVD regeneration and/or delay 
of it.  
The current knowledge on these cells is obscured and their specific requirements for ex vivo 
culture are not very clear. Current evidence confirms the presence of these cells in murine, 
canine, bovine and in the human fetal/surgical samples [3]. Interestingly, Tie2 is a marker for 
endothelial cells and it is not very clear what their origin and their role might be. Current data 
using a combination of molecular assays could identify these with about 2-5% in bovine 
coccygeal IVD samples of one-year age. In human surgical specimens their presence is more 
obscured depending on the donor’s age and the particular condition of the IVD (e.g. based on 
Pfirrmann grade) [2, 3].  
Here, I revisit the recent literature on regenerative cells identified for the IVD in the past 
decades. Current evidence how these NPPC can be isolated and detected in various species 
and tissues will be recapitulated. These NPPC are interesting to elaborate more closely from a 
developmental biology but also from an evolutionary point of you. Future directions will be 
provided how these progenitor cells could be used for regenerative medicine and tissue 
engineering.  
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